EFSA Releases Assessments of Two GM Maize for Import, Processing, and Food and Feed Uses within EU

The European Food Safety Authority (EFSA) Panel on Genetically Modified Organisms (GMO Panel) has published separate Scientific Opinions that report on the outcome of its risk assessment for two genetically modified (GM) maize, MON 89034 × 1507 × NK603 from Corteva Agriscience Belgium and Bayer Agriculture, and MON 94804 from Bayer Agriculture.

The scope of dossier GMFF-2022-3670 is for the renewal of the placing on the market of products containing maize MON 89034 × 1507 × NK603, for food and feed uses, excluding cultivation within the European Union (EU). Under the assumption that the DNA sequences of the events in maize MON 89034 × 1507 × NK603 considered for renewal are identical to the sequences of the originally assessed events, the GMO Panel concludes that there is no evidence in renewal dossier GMFF-2022-3670 for new hazards, modified exposure or scientific uncertainties that would change the conclusions of the original risk assessment for this GM maize.

Application GMFF-2022-10651 for maize MON 94804 is also for import, processing, and food and feed uses within the EU of maize MON 94804 and does not include cultivation in the EU. The GMO Panel finds that the consumption of food and feed from maize MON 94804 does not represent a nutritional concern in humans and animals and concludes that maize MON 94804 is as safe as the conventional counterpart and non-GM maize varieties tested, and no post-market monitoring of food/feed is necessary.

For more details, read the Scientific Opinions for GM maize MON 89034 × 1507 × NK603 and MON 94804 published in the EFSA Journal.